Trials / Completed
CompletedNCT00649389
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
A Randomized, Double-Blind, Parallel Group Study Evaluating the Efficacy and Safety of Co-Administration of a Triple Combination Therapy of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Subjects With Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,500 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effectiveness of four different strength combinations of three approved anti-hypertension therapies (olmesartan medoxomil, amlodipine, and hydrochlorothiazide) for lowering blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | 40mg olmesartan medoxomil |
| DRUG | Amlodipine | Amlodipine 10mg |
| DRUG | Hydrochlorothiazide | Hydrochlorothiazide 25mg |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-04-01
- Completion
- 2009-12-01
- First posted
- 2008-04-01
- Last updated
- 2019-01-09
- Results posted
- 2010-09-01
Locations
232 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00649389. Inclusion in this directory is not an endorsement.